⌘K

Home/Insiders/Abrahmsen Lars B.

AL

SEC Insider//CIK 0001789039

Abrahmsen Lars B.

CIK 00017890391 companyBOSTON, MA

Transactions

12

Companies

1

Filings

6

CIK

0001789039

Recent Transactions

12 trades

Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2022-03-10+24,700→ 43,700 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2022-03-10+100,000→ 100,000 total
Sale
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-10-01$4.89/sh−50,000→ 19,000 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-10-01$0.92/sh+50,000→ 69,000 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2021-10-01−50,000→ 30,587 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2021-09-20−25,000→ 80,587 total
Sale
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-09-20$4.97/sh−25,000→ 19,000 total
Exercise/Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-09-20$0.92/sh+25,000→ 44,000 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2021-02-25+82,000→ 82,000 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2021-02-25+19,000→ 19,000 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2020-03-24+31,600→ 31,600 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2019-10-07+77,630→ 77,630 total

Companies

1

Aprea Therapeutics, Inc.
SVP, Chief Scientific Officer
$APRE

Recent Filings

6

Address

535 BOYLSTON STREET

BOSTON, MA, 02116

View on SEC.gov